Topotecan Hydrochloride for Injection Clinical Trials
2 recruitingDrug
Phase 32
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer
Recurrent Cervical CancerMetastatic Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.398 enrolled1 locationNCT07418749
Recruiting
Phase 3
A Study of SHR-A1811 in Subjects With Ovarian Cancer
Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd.300 enrolled2 locationsNCT06828354